SCHEMBL15528336

SCHEMBL15528336

COc1cc2cccc(C)c2n1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 2/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
MCL1 Q07820 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CCR2 P41597 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA12 O43570 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30933380 1.00 PLA2G10 (0.36) PLA2G10MEN1KMT2AKDM4EALDH1A1
SCHEMBL15528596 0.82 PLA2G10 (0.33) PLA2G10MEN1KMT2AKDM4EL3MBTL1
SCHEMBL29149059 0.81 NR1H2 (0.41) CA12CA9
SCHEMBL3847463 0.76 MCL1 (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL29148947 0.75 ALDH1A1 (0.40) PLA2G10MEN1KMT2AKDM4EALDH1A1
SCHEMBL15971081 0.72 KDM4E (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL28550759 0.68 MCL1 (0.44) PLA2G10KDM4EALDH1A1HPGDHSD17B10
SCHEMBL31462830 0.67 NR1H2 (0.43) MEN1KMT2A
SCHEMBL9354562 0.66 CA12 (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL10233030 0.66 MCL1 (0.57) PLA2G10KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855456-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF Novartis AG (CH) 2015-04-08 EP disclosed
WO-2013164802-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2013-11-07 WO disclosed